Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions
NCT ID: NCT01845207
Last Updated: 2016-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2012-01-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Surgery as a Means of Reversing Frailty
NCT04875923
Frailty and Mortality in Older Old With Severe Aortic Stenosis
NCT02745314
Frailty in Elderly Patients Receiving Surgical or Percutaneous Procedures for Valvular Disorders
NCT03365453
Comparison of Different Frailty Assessment Tools
NCT04222400
Prehabilitation to Improve Functional and Clinical Outcomes in Patients With Aortic Stenosis
NCT02597985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aortic valve replacement
Patients aged ≥70 years referred for surgical or transcatheter aortic valve replacement.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Severe AS
3. Referred for surgical or transcatheter AVR (with or without concomitant revascularization)
4. Signed informed consent
Exclusion Criteria
2. Clinical instability: decompensated heart failure, active ischemia, unstable vital signs
3. Severe neuropsychiatric impairment
4. Not English or French speaking
5. Replacement of \>1 valve or aortic surgery
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Deaconess Medical Center
OTHER
Brigham and Women's Hospital
OTHER
Duke University
OTHER
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
OTHER
Massachusetts General Hospital
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
McMaster University
OTHER
Montreal Heart Institute
OTHER
Royal Victoria Hospital, Canada
OTHER
St. Boniface Hospital
OTHER
Unity Health Toronto
OTHER
St. Paul's Hospital, Canada
OTHER
Ottawa Heart Institute Research Corporation
OTHER
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Afilalo
MD MSc FACC FRCPC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Afilalo, MD MSc
Role: PRINCIPAL_INVESTIGATOR
Jewish General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Duke University Medical Center
Durham, North Carolina, United States
St. Paul's Hospital
Vancouver, British Columbia, Canada
St. Boniface Hospital
Winnipeg, Manitoba, Canada
Hamilton General Hospital
Hamilton, Ontario, Canada
Ottawa Heart Institute
Ottawa, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Centre Hospitalier Universite de Montreal
Montreal, Quebec, Canada
Montreal Heart Institute
Montreal, Quebec, Canada
Royal Victoria Hospital
Montreal, Quebec, Canada
Hôpital Jacques Cartier
Massy, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shi SM, Sung M, Afilalo J, Lipsitz LA, Kim CA, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Lee J, Marcantonio ER, Kim DH. Delirium Incidence and Functional Outcomes After Transcatheter and Surgical Aortic Valve Replacement. J Am Geriatr Soc. 2019 Jul;67(7):1393-1401. doi: 10.1111/jgs.15867. Epub 2019 Mar 18.
Afilalo J, Lauck S, Kim DH, Lefevre T, Piazza N, Lachapelle K, Martucci G, Lamy A, Labinaz M, Peterson MD, Arora RC, Noiseux N, Rassi A, Palacios IF, Genereux P, Lindman BR, Asgar AW, Kim CA, Trnkus A, Morais JA, Langlois Y, Rudski LG, Morin JF, Popma JJ, Webb JG, Perrault LP. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017 Aug 8;70(6):689-700. doi: 10.1016/j.jacc.2017.06.024. Epub 2017 Jul 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MOP-123314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.